Healthcare provider profile · identity verified

Guari Mascaro, M.D

General Practice · MIAMI, FL · NPI 1265485213

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1022	147
Fenofibrate	Fenofibrate Nanocrystallized	733	137
Vitamin D2	Ergocalciferol (Vitamin D2)	726	163
Gabapentin	Gabapentin	600	99
Rosuvastatin Calcium	Rosuvastatin Calcium	585	100
Metformin Hcl	Metformin Hcl	541	90
Pantoprazole Sodium	Pantoprazole Sodium	497	77
Hydrochlorothiazide	Hydrochlorothiazide	487	66
Lisinopril	Lisinopril	487	64
Losartan Potassium	Losartan Potassium	467	77
Diclofenac Sodium	Diclofenac Sodium	431	100
Amlodipine Besylate	Amlodipine Besylate	386	54
Famotidine	Famotidine	380	62
Omeprazole	Omeprazole	373	63
Levothyroxine Sodium	Levothyroxine Sodium	343	49
Ibuprofen	Ibuprofen	258	58
Metoprolol Tartrate	Metoprolol Tartrate	252	38
Meclizine Hcl	Meclizine Hcl	250	39
Baclofen	Baclofen	235	70
Albuterol Sulfate Hfa	Albuterol Sulfate	205	35
Folic Acid	Folic Acid	204	49
Glipizide	Glipizide	196	25
Metoclopramide Hcl	Metoclopramide Hcl	190	26
Methocarbamol	Methocarbamol	183	35
Tamsulosin Hcl	Tamsulosin Hcl	179	29
Montelukast Sodium	Montelukast Sodium	128	23
Furosemide	Furosemide	124	20
Enalapril Maleate	Enalapril Maleate	116	22
Clopidogrel	Clopidogrel Bisulfate	114	19
Carvedilol	Carvedilol	109	17
Sildenafil Citrate	Sildenafil Citrate	98	15
Meloxicam	Meloxicam	97	21
Simvastatin	Simvastatin	91	16
Atenolol	Atenolol	87	17
Chlorthalidone	Chlorthalidone	81	14
Metoprolol Succinate	Metoprolol Succinate	80	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	13
Alendronate Sodium	Alendronate Sodium	72	13
Azithromycin	Azithromycin	71	50
Ciclopirox	Ciclopirox	71	20
Triamcinolone Acetonide	Triamcinolone Acetonide	71	25
Clonidine Hcl	Clonidine Hcl	69	suppressed
Allopurinol	Allopurinol	67	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	15
Solifenacin Succinate	Solifenacin Succinate	61	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	57	22
Benzonatate	Benzonatate	57	20
Ezetimibe	Ezetimibe	56	12
Fluticasone Propionate	Fluticasone Propionate	51	17
Glimepiride	Glimepiride	51	suppressed
Eliquis	Apixaban	50	suppressed
Naproxen	Naproxen	50	14
Oxybutynin Chloride	Oxybutynin Chloride	49	suppressed
Propranolol Hcl	Propranolol Hcl	45	suppressed
Cilostazol	Cilostazol	44	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	44	14
Prednisone	Prednisone	44	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	suppressed
Latanoprost	Latanoprost	41	suppressed
Tadalafil	Tadalafil	41	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Diclofenac Potassium	Diclofenac Potassium	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Jardiance	Empagliflozin	34	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	32	suppressed
Labetalol Hcl	Labetalol Hcl	32	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Ketoconazole	Ketoconazole	30	11
Entresto	Sacubitril/Valsartan	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	21
Janumet	Sitagliptin Phos/Metformin Hcl	28	suppressed
Brilinta	Ticagrelor	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Colchicine	Colchicine	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Amoxicillin	Amoxicillin	21	17
Buspirone Hcl	Buspirone Hcl	21	suppressed
Pentoxifylline	Pentoxifylline	21	suppressed
Valsartan	Valsartan	21	suppressed
Nystatin	Nystatin	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Finasteride	Finasteride	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Celecoxib	Celecoxib	17	suppressed
Letrozole	Letrozole	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Verapamil Hcl	Verapamil Hcl	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Ciclopirox	Ciclopirox Olamine	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Trazodone Hcl	Trazodone Hcl	14	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Propafenone Hcl	Propafenone Hcl	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Procto-Med Hc	Hydrocortisone	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error